- AstraZeneca (NASDAQ:AZN) has partnered with CCT Research (CCT), a clinical research company to advance COVID-19 research.
- Together with local healthcare providers, CCT will facilitate clinical trials for the AZD1222 COVID-19 vaccine.
- CCT is recruiting eligible study participants who are 18-85 years old, not pregnant, in good general health and have not been previously diagnosed with COVID-19.
- This study compares an investigational vaccine against a placebo to see if the vaccine can prevent COVID-19 and will take place in Phoenix, Arizona.
https://seekingalpha.com/news/3635432-astrazeneca-teams-up-cct-to-conduct-covidminus-19-vaccine-trials-in-arizona
Thursday, November 12, 2020
AstraZeneca teams up with CCT to conduct COVID-19 vaccine trials in Arizona
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.